User profiles for Sheri Harari

Sheri Harari

Postdoctoral fellow, Fred Hutch Cancer Center
Verified email at fredhutch.org
Cited by 523

[HTML][HTML] Drivers of adaptive evolution during chronic SARS-CoV-2 infections

S Harari, M Tahor, N Rutsinsky, S Meijer, D Miller… - Nature medicine, 2022 - nature.com
In some immunocompromised patients with chronic severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection, considerable adaptive evolution occurs. Some …

[HTML][HTML] Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

T Kustin, N Harel, U Finkel, S Perchik, S Harari… - Nature medicine, 2021 - nature.com
The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension
exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of …

[HTML][HTML] Drivers of within-host genetic diversity in acute infections of viruses

M Gelbart, S Harari, Y Ben-Ari, T Kustin, D Wolf… - PLoS …, 2020 - journals.plos.org
Genetic diversity is the fuel of evolution and facilitates adaptation to novel environments.
However, our understanding of what drives differences in the genetic diversity during the early …

[HTML][HTML] Using big sequencing data to identify chronic SARS-Coronavirus-2 infections

S Harari, D Miller, S Fleishon, D Burstein… - Nature …, 2024 - nature.com
The evolution of SARS-Coronavirus-2 (SARS-CoV-2) has been characterized by the periodic
emergence of highly divergent variants. One leading hypothesis suggests these variants …

[HTML][HTML] Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography

E Shteyer, L Shekhtman, T Zinger, S Harari… - Plos one, 2019 - journals.plos.org
Background & aims Acute hepatitis C (AHC) is not frequently identified because patients are
usually asymptomatic, although may be recognized after iatrogenic exposures such as …

Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects

…, YB On, E van Thijn, N Rutsinsky, S Harari… - Journal of Infection and …, 2024 - Elsevier
In hemato-oncological patients, COVID-19 can present as a persistent infection with ongoing
symptoms and viral replication over a prolonged period of time. Data are scarce on the …

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography

E Shteyer, L Shekhtman, T Zinger, S Harari… - Plos one, 2019 - journals.plos.org
There are errors in the Author Contributions. The correct contributions are: Conceptualization:
ES, HD, YL. Data curation: ES, IG, DW, ID, DA, MCE, YS, GSB, HD, YL. Formal analysis: LS…

[HTML][HTML] Saccharomyces cerevisiae as a Toolkit for COP9 Signalosome Research

D Harshuk-Shabso, N Castel, R Israeli, S Harari, E Pick - Biomolecules, 2021 - mdpi.com
The COP9 signalosome (CSN) is a highly conserved eukaryotic multi-subunit enzyme, regulating
cullin RING ligase activities and accordingly, substrate ubiquitination and degradation. …

[PDF][PDF] AccuNGS: Detecting ultra-rare variants in viruses from clinical samples

M Gelbart, S Harari, YA Ben-Ari, T Kustin, D Wolf… - …, 2018 - pdfs.semanticscholar.org
Next generation sequencing is widely used to characterize genetic diversity in a sample, yet
is hindered by its relatively low resolution. Particularly, detecting rare genetic variants in …

AccuNGS: a sequencing protocol for detection of ultra-rare variants reveals extensive variation in HIV during first days of infection

M Gelbart, S Harari, Y Ben-Ari, T Kustin, M Meir… - bioRxiv, 2018 - biorxiv.org
Next generation sequencing (NGS) is widely used to identify genetic diversity within a sample.
This includes basic scientific interrogations such as quantifying standing genetic variation …